RKLB is trading at $73.25 (+4.45%) as shares recover from the sharp selloff triggered by the announcement that the first Neutron rocket launch will slip to late 2026.
- The stock previously plunged 9.5% after a manufacturing defect in the stage 1 tank was discovered during January testing, but sentiment is stabilizing as the company's record $1.85 billion backlog remains intact.
- Investors are refocusing on Rocket Lab's strong fundamentals following a significant Q4 earnings beat despite the revised development timeline.
- Today's gains are further supported by broader market strength, with the NASDAQ up 1.50% and the S&P 500 up 0.85% in live trading.